761423-87-4
Price | USD166.00 |
Packge | 5g/Bag |
- Min. Order:5g
- Supply Ability:100kg
- Time:2022-03-18
Product Details
- Product Name(1S)-1,5-Anhydro-1-C-[3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl]-D-glucitol
- CAS No.761423-87-4
- MFC21H21FO5S
- MW404.45
- AppearanceSolidWhite to Off-White
- density 1.452
- Boiling point 628.8±55.0 °C(Predicted)
- storage temp. Refrigerator
- Melting point 155-157°C
Ipragliflozin L-proline was approved in Japan in January 2014 for the treatment of type 2 diabetes. The drug was discovered by Astellas Pharma and co-developed and marketed with Kotobuki Pharmaceutical and Merck Sharp Dohme as Suglat?. Similar to empagliflozin (XIII), ipragliflozin L-proline is a sodium-glucose 1956 A. C. Flick et al. / Bioorg. Med. Chem. 24 (2016) 1937–1980 co-transporter-2 inhibitor which prevents glucose reabsorption by excreting excess glucose in the urine. Ipragliflozin exhibits remarkable selectivity over SLGT-1 (>250x).
Company Profile Introduction
-
Recommended supplier
-
VIP1年
- Metrochem API Private Limited
- Ipragliflozin L-proline 98%
- Inquiry
- 2024-01-03
-
VIP1年
- Vijaya Pharma And Life Science
- 488787-59-3 / 128173-52-4 98%
- Inquiry
- 2024-03-13
- Since:2008-05-08
- Address: No.10,the 4th road of High-tech zone, Baoji City, Shaan’xi province, Mainland China
INQUIRY